Jefferies Downgrades TCR2 Therapeutics to Underperform, Lowers Price Target to $3
Jefferies analyst Kelly Shi downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Underperform and lowers the price target from $18 to $3.
JP Morgan Downgrades Qualtrics International to Neutral, Raises Price Target to $18
JP Morgan analyst Mark Murphy downgrades Qualtrics International (NASDAQ:XM) from Overweight to Neutral and raises the price target from $16 to $18.
Morgan Stanley Downgrades Diversey Hldgs to Equal-Weight, Raises Price Target to $8.4
Morgan Stanley analyst Vincent Andrews downgrades Diversey Hldgs (NASDAQ:DSEY) from Overweight to Equal-Weight and raises the price target from $8 to $8.4.
Barclays Downgrades Hyatt Hotels to Equal-Weight, Lowers Price Target to $125
Barclays analyst Brandt Montour downgrades Hyatt Hotels (NYSE:H) from Overweight to Equal-Weight and lowers the price target from $130 to $125.
WeightWatchers Analyst Expects Stock To Slim Down After Gaining 80% On Telehealth Takeover
One WW International Inc (NASDAQ: WW) analyst downgraded the shares on Wednesday, and it has less to do with the company itself and more to do with the abnormal surge in the stock this week.
Tesla Analyst Says ‘Weaponized’ Capacity Is Already Priced In: Is Elon Musk Playing Chess While Other Automakers Play Catch Up?
As Tesla Inc (NASDAQ: TSLA) sacrifices margins to drive increased volumes, one analyst says the stock is likely to be stuck in neutral — but the automaker's approach could still be the correct one in the
JP Morgan Downgrades TDCX to Neutral, Lowers Price Target to $12.1
JP Morgan analyst Ranjan Sharma downgrades TDCX (NYSE:TDCX) from Overweight to Neutral and lowers the price target from $14.1 to $12.1.
Odeon Capital Downgrades Bank of America to Hold, Announces $35.2 Price Target
Odeon Capital analyst Dick Bove downgrades Bank of America (NYSE:BAC) from Buy to Hold and announces $35.2 price target.
JP Morgan Downgrades Offerpad Solutions to Neutral
JP Morgan analyst Dae Lee downgrades Offerpad Solutions (NYSE:OPAD) from Overweight to Neutral.
HSBC Downgrades TDCX to Hold, Announces $13 Price Target
HSBC analyst Shuo Han Tan downgrades TDCX (NYSE:TDCX) from Buy to Hold and announces $13 price target.